The principals at DevelRx each have more than 25 years of experience in research and development of central nervous system (CNS) drugs used in psychiatry (e.g. Addiction / dependence, ADHD, binge-eating disorder) and neurology that has been gained from successful careers in academic research, the pharmaceutical and biotech industry and as founder / senior members of a CRO, RenaSci Ltd (UK). David Heal was a founder member of RenaSci Ltd at BioCity in Nottingham in 2001 after leaving Knoll Pharmaceuticals (BASF Pharma).
DevelRx is a consultancy business that provides expert input on CNS drug discovery and development, drug abuse evaluation and treatment to our clients in all sectors of the worldwide pharmaceutical and biotech industry. David Heal has been joined in this venture by the key members of the RenaSci Consultancy Team, Sharon Smith and Jane Gosden.
DevelRx is a consultancy business that provides expert input on CNS drug discovery and development, drug abuse evaluation and treatment to our clients in all sectors of the worldwide pharmaceutical and biotech industry. David Heal has been joined in this venture by the key members of the RenaSci Consultancy Team, Sharon Smith and Jane Gosden.
Location: United Kingdom, England, Nottingham
Employees: 1-10
Founded date: 2020